Literature DB >> 21191699

Surgical impacts of an en bloc resection of the diaphragm for hepatocellular carcinoma with gross diaphragmatic involvement.

Yo-ichi Yamashita1, Kazutoyo Morita, Tomohiro Iguchi, Eiji Tsujita, Yuji Soejima, Akinobu Taketomi, Yoshihiko Maehara.   

Abstract

PURPOSE: Diaphragmatic involvement is relatively uncommon in patients undergoing a hepatectomy for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the short- and long-term surgical impacts of HCC with gross diaphragmatic involvement in patients undergoing an en bloc resection of the diaphragm.
METHODS: Between 1990 and 2007, 911 patients with HCC underwent a hepatectomy at our institution. Twenty-seven patients (3.0%) had had gross involvement of the diaphragm. Thirteen patients (1.4%) had undergone an en bloc resection of the diaphragm, and 14 (1.5%) had received only a blunt dissection. The short-term surgical impacts (surgical morbidity and mortality) and long-term surgical impacts (overall and disease-free survival) were compared between the groups.
RESULTS: In patients with an en bloc resection of the diaphragm as compared with those who received a blunt dissection, the values of total bilirubin and the indocyanine green retention rate at 15 min were significantly better (P < 0.01 and P = 0.04, respectively), and the rate of positivity for the hepatitis B antigen was significantly higher (P = 0.02). The positive rates of microscopic fibrocapsular invasion (P = 0.03), microscopic vascular invasion (P = 0.04), and Ki-67 immunostaining (P = 0.04) were significantly higher in patients with an en bloc resection of the diaphragm. There were no significant differences in the short-term and long-term surgical impacts between the groups.
CONCLUSION: An en bloc resection of the diaphragm in patients with gross diaphragmatic involvement of HCC is therefore justified, since there are no significant differences in short- or long-term surgical impacts in comparison with the patients receiving blunt dissection.

Entities:  

Mesh:

Year:  2010        PMID: 21191699     DOI: 10.1007/s00595-010-4289-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  Clinicopathological study of hepatocellular carcinoma with diaphragmatic involvement.

Authors:  K F Leung; A K Chui; K L Leung; P B Lai; C T Liew; W Y Lau
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  Surgical results of hepatic resection for hepatocellular carcinoma with gross diaphragmatic invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Jung-Ta Chen; Chia-Cheng Lin; Tse-Jia Liu
Journal:  Hepatogastroenterology       Date:  2005 Sep-Oct

3.  Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s).

Authors:  W Y Tung; G Y Chau; C C Loong; J C Wu; S H Tsay; K L King; S M Huang; J H Chiu; C W Wu; W Y Lui
Journal:  Eur J Surg Oncol       Date:  1996-10       Impact factor: 4.424

4.  Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases.

Authors:  K Yuki; S Hirohashi; M Sakamoto; T Kanai; Y Shimosato
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

5.  Appraisal of a manual blunt dissection for an intraoperative diagnosis of extrahepatic cancer invasion.

Authors:  T Ezaki; N Koyanagi; T Toyomasu; Y Ikeda; N Nakanishi; K Sugimachi
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

6.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

7.  En bloc resection for extensive hepatocellular carcinoma: is it advisable?

Authors:  K S Jeng; B F Chen; H J Lin
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

8.  Resection of hepatocellular carcinoma with diaphragmatic invasion.

Authors:  W Y Lau; K L Leung; T W Leung; C T Liew; M Chan; A K Li
Journal:  Br J Surg       Date:  1995-02       Impact factor: 6.939

  8 in total
  11 in total

1.  Surgical outcome of extended liver resections for colorectal liver metastasis compared with standard liver resections.

Authors:  Go Shinke; Takehiro Noda; Hidetoshi Eguchi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Yutaka Takeda; Masahiro Tanemura; Tsunekazu Mizushima; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Mol Clin Oncol       Date:  2018-05-18

2.  Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival.

Authors:  Masayuki Okuno; Claire Gourmard; Takashi Mizuno; Kiyohiko Omichi; Ching-Wei D Tzeng; Yun Shin Chun; Jeffrey E Lee; Jean-Nicolas Vauthey; Claudius Conrad
Journal:  HPB (Oxford)       Date:  2017-09-22       Impact factor: 3.647

Review 3.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

4.  ASO Author Reflections: Is Hepatectomy Plus Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement Justified?

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Akinobu Taketomi
Journal:  Ann Surg Oncol       Date:  2020-06-23       Impact factor: 5.344

5.  Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Kenji Wakayama; Shingo Shimada; Akihisa Nagatsu; Yoh Asahi; Yuzuru Sakamoto; Hirofumi Kamachi; Akinobu Taketomi
Journal:  Ann Surg Oncol       Date:  2020-06-25       Impact factor: 5.344

6.  Should diaphragmatic involvement preclude resection of large hepatic tumors?

Authors:  Nikolaos Arkadopoulos; Maria A Kyriazi; Apostolos Perelas; Kassiani Theodoraki; Evangelia Papantoni; Panagiotis Kokoropoulos; Nikolaos Danias; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

7.  Interleukin-12 inhibits the hepatocellular carcinoma growth by inducing macrophage polarization to the M1-like phenotype through downregulation of Stat-3.

Authors:  Qin Wang; Feng Cheng; Ting-Ting Ma; Hai-Yu Xiong; Zi-Wei Li; Chang-Li Xie; Cui-Ying Liu; Zhi-Guang Tu
Journal:  Mol Cell Biochem       Date:  2016-03-22       Impact factor: 3.396

8.  One stage resection of spontaneous rupture of hepatocellular carcinoma in the triangular ligament with diaphragm invasion: case report and review of the literature.

Authors:  Kwang-Kuk Park; Song-I Yang; Myung-Hee Yoon
Journal:  World J Emerg Surg       Date:  2012-09-21       Impact factor: 5.469

9.  Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate.

Authors:  Ran Tao; Zhong-Feng Wang; Wei Qiu; Yu-Fang He; Wei-Qun Yan; Wen-Yi Sun; Hai-Jun Li
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

10.  Laparoscopic liver resection with simultaneous diaphragm resection.

Authors:  Airazat M Kazaryan; Davit L Aghayan; Åsmund A Fretland; Vasiliy I Semikov; Alexander M Shulutko; Bjørn Edwin
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.